Purchases and Sales Made in Q2 2023 in In Med Pharmaceuticals Inc. (INM)
This table provides information about the institutional ownership of In Med Pharmaceuticals Inc. (INM) during Q2 2023. The information is specifically focused on institutions that hold shares of InMed Pharmaceuticals Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 14, 2023
Q2 2023
|
Bank Of America Corp
Charlotte, NC |
BUY
|
- |
12+ 0.66% |
$10.8 - $16.8
|
1.83K
$440
|
|
|
Aug 14, 2023
Q2 2023
|
Royal Bank Of Canada
Toronto, A6 |
BUY
|
- |
7+ 63.64% |
$6.3 - $9.8
|
18
$4.32
|
|
|
Aug 10, 2023
Q2 2023
|
Advisor Group Holdings, Inc.
Phoenix, AZ |
BUY
|
- |
1+ 2.44% |
$0.9 - $1.4
|
42
$10.1
|
|
|
Aug 10, 2023
Q2 2023
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Aug 11, 2023
Q2 2023
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
SELL
|
- |
-5.15K- 27.35% |
$4.63K - $7.21K
|
13.7K
$3.28K
|